Skip to main content
Holiday Sale — Get 40% off Vantage for yourself or as a gift
Get Started
SubscribeLogin
Published • loading... • Updated

Wells Fargo & Company Issues Positive Forecast for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price

Summary by marketbeat.com
Wells Fargo & Company boosted their target price on shares of Regeneron Pharmaceuticals from $700.00 to $745.00 and gave the stock an "equal weight" rating in a research note on Wednesday.

1 Articles

marketbeat.commarketbeat.com
Center

Wells Fargo & Company Issues Positive Forecast for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price

Wells Fargo & Company boosted their target price on shares of Regeneron Pharmaceuticals from $700.00 to $745.00 and gave the stock an "equal weight" rating in a research note on Wednesday.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

marketbeat.com broke the news in on Wednesday, December 10, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Wells Fargo icon

Wells Fargo

Stock Markets icon

Stock Markets

United States icon

United States

US Economy icon

US Economy

Business & Markets icon

Business & Markets

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal